AnGes, Inc.
Status: Publicly traded
Direct answer
AnGes, Inc. is publicly traded on JPX under the ticker 4563.T.
AnGes, Inc., a biopharmaceutical firm headquartered in Ibaraki, Japan, and established in 1999, focuses on pioneering the research and development of gene-based medical solutions. Its primary therapeutic asset is Hepatocyte Growth Factor (HGF) Plasmid, an innovative gene therapy designed to address critical limb ischemia, a severe circulatory condition impacting the legs. The company's diverse pipeline also includes...
Can you invest in AnGes, Inc.?
Yes. AnGes, Inc. is publicly traded on JPX under the ticker 4563.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.